Relative Bioavailability of Olodaterol and Fluconazole
NCT01153724
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
35
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG:
BI 1744
DRUG:
Fluconazole
Sponsor
Boehringer Ingelheim